CytRx Corp. buy tbackenh
Start price
19.05.17
/
50%
€2.81
Target price
02.06.17
€6.49
Performance (%)
53.03%
End price
02.06.17
€4.30
Summary
This prediction ended on 02.06.17 with a price of €4.30. With a performance of 53.03% the BUY prediction by tbackenh was a big success. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | -1,36 % | -2,33 % | 3,44 % | 53,51 % |
| iShares Nasdaq 100 | -3,70 % | -1,24 % | 33,08 % | 90,97 % |
| iShares Nikkei 225® | -2,51 % | 6,91 % | 60,78 % | 81,10 % |
| iShares S&P 500 | -1,66 % | -0,64 % | 23,47 % | 67,07 % |
Comments by tbackenh for this prediction
In the thread CytRx Corp. diskutieren
CytRx Corp.
Interessant wird die Veröffentlichung der Phase-3-Studie in Q3. Ein positives Ergebnis könnte Rüclenwind bedeuten.
(Stop Loss Kurs erreicht)